- Home
- AU vs IDXX Comparison
AU vs IDXX Comparison
Compare AU & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AU | IDXX |
|---|---|---|
| Founded | 1944 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2B | 57.1B |
| IPO Year | 2023 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AU | IDXX |
|---|---|---|
| Price | $92.76 | $553.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $119.00 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 2.0M | 570.7K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.94% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 3.47 |
| Revenue | N/A | ★ $4,303,702,000.00 |
| Revenue This Year | $38.71 | $10.88 |
| Revenue Next Year | $2.89 | $8.59 |
| P/E Ratio | ★ $23.93 | $157.33 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $42.17 | $496.61 |
| 52 Week High | $129.14 | $769.98 |
Technical Indicators
Market Signals| Indicator | AU | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 47.70 |
| Support Level | $90.76 | $523.38 |
| Resistance Level | $113.70 | $595.15 |
| Average True Range (ATR) | 3.43 | 19.71 |
| MACD | -0.82 | 0.29 |
| Stochastic Oscillator | 20.68 | 48.04 |
Price Performance
Historical ComparisonAbout AU AngloGold Ashanti PLC
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.